atenolol has been researched along with Renal Insufficiency, Chronic in 7 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Baseline estimated GFR (eGFR) and change in eGFR during follow-up were examined in relation to average on-treatment SBP in 8778 hypertensive patients with ECG left ventricular hypertrophy (LVH) randomly assigned to losartan- or atenolol-based treatment." | 5.22 | Impact of achieved systolic blood pressure on renal function in hypertensive patients. ( Devereux, RB; Kjeldsen, SE; Okin, PM, 2016) |
| "Atenolol treatment initiation was associated with lower 90-day risk of mortality than metoprolol tartrate (incidence, 0." | 1.40 | Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults. ( Devereaux, PJ; Fleet, JL; Garg, AX; Jain, AK; McArthur, E; Ozair, S; Roberts, MA; Weir, MA, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Mitsuboshi, S | 1 |
| Niimura, T | 1 |
| Aizawa, F | 1 |
| Goda, M | 1 |
| Zamami, Y | 1 |
| Ishizawa, K | 1 |
| Duggal, V | 1 |
| Thomas, IC | 1 |
| Montez-Rath, ME | 1 |
| Chertow, GM | 1 |
| Kurella Tamura, M | 1 |
| Okin, PM | 1 |
| Kjeldsen, SE | 1 |
| Devereux, RB | 1 |
| Zoccali, C | 1 |
| Mallamaci, F | 1 |
| Fleet, JL | 1 |
| Weir, MA | 1 |
| McArthur, E | 1 |
| Ozair, S | 1 |
| Devereaux, PJ | 1 |
| Roberts, MA | 1 |
| Jain, AK | 1 |
| Garg, AX | 1 |
| Randhawa, SK | 1 |
| Elliott, WJ | 1 |
| Lely, AT | 1 |
| van der Kleij, FG | 1 |
| Kistemaker, TJ | 1 |
| Apperloo, AJ | 1 |
| de Jong, PE | 1 |
| de Zeeuw, D | 1 |
| Navis, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Triple-Blind, Parallel Study to Investigate the Effect of Losartan Versus Atenolol on the Reduction of Morbidity and Mortality in Hypertensive Patients With Left Ventricular Hypertrophy[NCT00338260] | Phase 3 | 496 participants (Actual) | Interventional | 1995-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for atenolol and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Impact of achieved systolic blood pressure on renal function in hypertensive patients.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Electrocardiography; Female; Glomerular Fil | 2016 |
Impact of the preintervention rate of renal function decline on outcome of renoprotective intervention.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Creatinine; Disease Progression; Enalapril | 2008 |
5 other studies available for atenolol and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Atenolol and mortality events in patients with chronic kidney disease: Analysis of data from the Japanese Adverse Drug Event Report database.
Topics: Adrenergic beta-Antagonists; Atenolol; Drug-Related Side Effects and Adverse Reactions; Female; Huma | 2022 |
National Estimates of CKD Prevalence and Potential Impact of Estimating Glomerular Filtration Rate Without Race.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anti-Bac | 2021 |
Cardiovascular protection by β-blockade in hypertensive haemodialysis patients: the Hypertension in Haemodialysis Patients Treated With Atenolol or Lisinopril (HDPAL) trial.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Cardiotonic Agents; Humans; Hyperten | 2014 |
Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Atenolol; Coh | 2014 |
Therapy: atenolol versus metoprolol tartrate--conflicting outcomes data.
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Female; Humans; Kidney; Male; Metoprolol; Populati | 2014 |